ABEO · Abeona Therapeutics Inc. · Executive Compensation
$5.25
+0.09 (+1.74%)
At close · Sep 30
Return incl. dividend (before tax)
Market Cap
$299.07M
Shares
57.18M
Volume · Sep 30
1.13M
Avg daily vol (3M)
1.44M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Edward Carr | Former Chief Accounting Officer and Chief Financial Officer | $1,569,879 |
| Brendan O’Malley | General Counsel | $1,179,209 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Michael Amoroso | Former President and Chief Executive Officer Fair value of option awards is calculated under ASC 718 as of the grant date using the Black-Scholes option-pricing model and as of the repricing date using a Hull-White I lattice model. Employees are assumed to exercise their options. The determination of the fair value of share-based payment awards made on the date of grant is affected by our Common Stock price as well as assumptions regarding a number of complex and subjective variables. Our assumptions in determining fair value are described in Note 11 of Notes to Consolidated Financial Statements in Part II, Item 8 of the Annual Report. | $1,499,160 |
| Edward Carr | Former Chief Accounting Officer and Chief Financial Officer | $924,007 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Michael Amoroso | member of the Board of Directors | Resigned | 2026-06-12 |
| Keith A. Goldan | Chair of the Audit Committee | Appointed | 2026-04-07 |
| Keith A. Goldan | member of the Board of the Company as a Class 1 director | Appointed | 2026-04-07 |
| Eric Crombez | member of the Board | Appointed | 2024-08-14 |
| Bernhardt G. Zeiher | member of the Board | Appointed | 2024-08-14 |
| Vishwas Seshadri | Class 2 director | Appointed | 2024-04-24 |
| Leila Alland | Class 2 director | Appointed | 2024-04-24 |
| Michael Amoroso | Chairman of the Board | Appointed | 2023-04-11 |